Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
10/28/1998 | EP0874054A2 Vector for the expression of immunoglobulin-cytokine fusionproteins in malignant B Cells |
10/28/1998 | EP0874053A2 3-Dehydroquinate synthase (aroB) |
10/28/1998 | EP0874051A2 OSP a protein of borrelia burgdorferi subgroups, encoding genes and vaccines. |
10/28/1998 | EP0874050A2 Integrin ligand ITGL-TSP |
10/28/1998 | EP0874049A1 Nucleic acid sequences of CIITA genes |
10/28/1998 | EP0874048A2 Human hedgehog protein |
10/28/1998 | EP0874047A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor |
10/28/1998 | EP0874046A1 A novel signal transduction factor and a gene encoding the same |
10/28/1998 | EP0874045A1 Novel dnas and process for producing proteins by using the same |
10/28/1998 | EP0873999A1 Antibody to the prorenin profragment, renin-active substance containing the same and prorenin assay reagent using the same |
10/28/1998 | EP0873998A2 Receptor protein and its use |
10/28/1998 | EP0873491A1 Ceramic packing with channels for thermal and catalytic beds |
10/28/1998 | EP0873423A1 Methods for detecting mutations associated with hypertrophic cardiomyopathy |
10/28/1998 | EP0873417A1 Compositions for the detection of proteases in biological samples and methods of use thereof |
10/28/1998 | EP0873415A1 Fusion protein delivery system and uses thereof |
10/28/1998 | EP0873409A1 Equine rhinovirus 1 proteins |
10/28/1998 | EP0873408A1 Calcium binding proteolipid compositions and methods |
10/28/1998 | EP0873407A1 Apo-2 ligand |
10/28/1998 | EP0873406A2 Protein induced by deprenyl |
10/28/1998 | EP0873404A1 Angiotensin converting enzyme inhibitors |
10/28/1998 | EP0873401A1 Novel retrovirus and diagnostic methods |
10/28/1998 | EP0873399A1 Monoclonal lymphocytes and methods of use |
10/28/1998 | EP0873361A2 Nuclear receptor ligands and ligand binding domains |
10/28/1998 | EP0873360A1 Transforming growth factor alpha hiii |
10/28/1998 | EP0873359A1 Regulator of cell proliferation |
10/28/1998 | EP0873358A2 Capturing of microorganisms using complement components |
10/28/1998 | EP0873357A2 Antithrombotic agents and methods of use |
10/28/1998 | EP0873354A1 Novel amp activated protein kinase |
10/28/1998 | EP0873353A1 IgG SEPARATION MEDIUM AND NOVEL PROTEIN A VARIANT |
10/28/1998 | EP0873350A1 Isolated nucleic acid molecule which encodes murine tumor rejection antigen precursor smage-3 |
10/28/1998 | EP0873349A1 Endothelial-monocyte activating polypeptide iii |
10/28/1998 | EP0873348A1 Human vascular endothelial growth factor 3 |
10/28/1998 | EP0873141A1 Compositions and methods for therapeutic use |
10/28/1998 | EP0873138A2 Improved pharmaceutical compositions |
10/28/1998 | EP0873135A1 Peanut allergens and methods |
10/28/1998 | EP0873132A1 PROTEIN WHICH INTERACTS WITH THE HUNTINGTON'S DISEASE GENE PRODUCT, cDNA CODING THEREFOR, AND ANTIBODIES THERETO |
10/28/1998 | EP0873049A1 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
10/28/1998 | EP0605484B1 Peptides having growth hormone releasing activity |
10/28/1998 | EP0587719B1 DETECTION OF COLLAGEN DEGRADATION $i(IN VIVO) |
10/28/1998 | EP0407392B2 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES |
10/28/1998 | CN1197483A Inducible herbicide resistance |
10/28/1998 | CN1197461A Truncated glial cell line-derived neurotrophic factor |
10/28/1998 | CN1197460A Cyclic peptide analogs of somatostatin |
10/28/1998 | CN1197393A Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof |
10/28/1998 | CN1197392A Prepn. of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form |
10/28/1998 | CN1197281A Plasma display panel device and method of fabricating the same |
10/28/1998 | CN1197077A Nucleic acid construct for cell cycle regulated expression of structural genes |
10/28/1998 | CN1196956A Influenza vaccine |
10/28/1998 | CN1040432C Spiro piperdines derivatives and its prepn. and applications |
10/28/1998 | CA2231746A1 A human sodium dependent phosphate transporter (ipt-1) |
10/27/1998 | US5827934 Cytotoxic diphtheria toxin fragments |
10/27/1998 | US5827826 Compositions of human endothelial cell growth factor |
10/27/1998 | US5827825 Polypeptide from the condensation of variable hexa- or heptapeptides with peptides containing twelve to twenty units of leucine and/or norleucine, for treatment of respiratory disorders |
10/27/1998 | US5827824 Protease-resistant thrombomodulin analogs |
10/27/1998 | US5827821 Conformationally stabilized cell adhesion peptides |
10/27/1998 | US5827818 Anticoagulants; administered by injections along with a carrier |
10/27/1998 | US5827817 P-selectin ligand protein |
10/27/1998 | US5827816 Bactericide for gram-negative bacteria infection; a polypeptide with a cysteine at position 132 replaced by different amino acid |
10/27/1998 | US5827750 Human virus associated with chronic fatigue immune deficiency syndrome and assay therefore |
10/27/1998 | US5827738 Sustainable chick cell line infected with Marek's disease virus |
10/27/1998 | US5827737 Stable drosophila cell line |
10/27/1998 | US5827735 Pluripotent mesenchymal stem cells and methods of use thereof |
10/27/1998 | US5827734 Materials and methods for determining ob protein in a biological sample |
10/27/1998 | US5827733 Growth differentiation factor-8 (GDF-8) and polynucleotides encoding same |
10/27/1998 | US5827731 Anticoagulant |
10/27/1998 | US5827730 Protein containing atleast one amino acid glycine subsituted by arginine at position 972 and such substitution interferes with signal transduction through insulin receptor substrate-1 |
10/27/1998 | US5827718 Lipase, microorganisms producing the lipase, method of producing the lipase and use of the lipase |
10/27/1998 | US5827712 Culturing with a gene encoding a heat shock protein enhancing to produce a soluble transglutaminase |
10/27/1998 | US5827708 Nucleotide sequence which codes for the polypeptide expressed by transfer ribonucleic acid synthetase gene; screening for antibacterial compounds; from genetically enginered cells |
10/27/1998 | US5827703 Methods and composition for in vivo gene therapy |
10/27/1998 | US5827696 Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system |
10/27/1998 | US5827695 Detection of wheat fungal pathogens using the polymerase chain reaction |
10/27/1998 | US5827694 Bovine, porcine, feline, rabbit interferons |
10/27/1998 | US5827693 Expression of recombinant hemoglobin and hemoglobin variants in yeast |
10/27/1998 | US5827692 Parasiticides against heartworm, elephantiasis |
10/27/1998 | US5827691 Process for preparing a protein which inhibits metastasis of cancer |
10/27/1998 | US5827689 Encoding fatty acid biosynthesis (fabd) polypeptides expressed in bacterial genes; vaccines, immunology |
10/27/1998 | US5827688 Secreted proteins and polynucleotides encoding them |
10/27/1998 | US5827686 Method of expressing genes in mammalian cells |
10/27/1998 | US5827685 Methods and compositions of genetic stress response systems |
10/27/1998 | US5827684 Production of Bacillus entomotoxins in methylotrophic yeast |
10/27/1998 | US5827672 Human monocyte elastase inhibitor antibodies |
10/27/1998 | US5827671 Antibodies raised against proteins of Leishmania which are expressed at an increased level in the amastigote form |
10/27/1998 | US5827668 Immunodiagnostic assay for rheumatoid arthritis |
10/27/1998 | US5827666 Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
10/27/1998 | US5827659 Methods and apparatus for sequencing polymers using mass spectrometry |
10/27/1998 | US5827655 Product of the mk3 gene; identifying immune response |
10/27/1998 | US5827654 Basal body rod protein genes of campylobacter |
10/27/1998 | US5827647 Treating samples with isolated empty parvovirus capsids, then detecting antigen-antibody complexes for diagnosis, also kits |
10/27/1998 | US5827646 Comprising isolated epstein barr virus structural antigen and epstein barr nuclear antigen 1 |
10/27/1998 | US5827534 Oral dosage composition comprising zonnula occludens toxin and a therapeutic agent for intestinal delivery |
10/27/1998 | US5827519 Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use |
10/27/1998 | US5827518 Insect immunosuppressants; insecticides |
10/27/1998 | US5827516 Decreasing major histocompatibility complex class ii antigen in mammal by introducing into antigen presenting cell an expression vector comprising a nucleic acid molecule coding for expression of peptide which binds to mhc class ii molecule |
10/27/1998 | US5827515 Obtaining a dna segemnt containing spov dna sequence, introducing the segment into a bacillus thuringiensis host, isolating genetically engineered mutant capable of expressing exogenous crystal protein |
10/27/1998 | US5827514 Pesticidal compositions |
10/27/1998 | US5827073 Photoreactive peptide derivatives |
10/27/1998 | CA2107216C Polyamino acid superabsorbents |
10/27/1998 | CA2078694C Hepatitis b vaccine |
10/27/1998 | CA2063721C Mycobacterium chelonae polar glycopeptidolipids-based immune booster medication |